The development of a commercial route
toward the JAK1 inhibitor
abrocitinib is described. The application of a late-stage Lossen rearrangement
provided the desired cis-diaminocyclobutane, which
was subsequently sulfonylated using a novel water-tolerable triazole
sulfonylating reagent to provide the active pharmaceutical ingredient.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.